4.8 Article

L3MBTL1, a histone-methylation-dependent chromatin lock

期刊

CELL
卷 129, 期 5, 页码 915-928

出版社

CELL PRESS
DOI: 10.1016/j.cell.2007.03.048

关键词

-

资金

  1. ICREA Funding Source: Custom
  2. NATIONAL CANCER INSTITUTE [R01CA085826, R01CA113863, R01CA102202] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064844, F32GM071166] Funding Source: NIH RePORTER
  4. NCI NIH HHS [CA 102202, CA085826, CA113863] Funding Source: Medline
  5. NIGMS NIH HHS [GM-71166, GM-64844] Funding Source: Medline

向作者/读者索取更多资源

Distinct histone lysine methylation marks are involved in transcriptional repression linked to the formation and maintenance of facultative heterochromatin, although the underlying mechanisms remain unclear. We demonstrate that the malignant-brain-tumor (MBT) protein L3MBTL1 is in a complex with core histones, histone H1b, HP1 gamma, and Rb. The MBT domain is structurally related to protein domains that directly bind methylated histone residues. Consistent with this, we found that the L3MBTL1 MBT domains compact nucleosomal arrays dependent on mono- and dimethylation of histone H4 lysine 20 and of histone H1b lysine 26. The MBT domains bind at least two nuclecisomes simultaneously, linking repression of transcription to recognition of different histone marks by L3MBTL1. Consistently, L3MBTL1 was found to negatively regulate the expression of a subset of genes regulated by E2F, a factor that interacts with Rb.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据